🔎 Trials Near Me

Akèy › Kansè bronch › Tennessee

Etid klinik pou Kansè bronch nan Tennessee

4 etid pou Kansè bronch ap chèche patisipan nan sit nan Tennessee.

Vil nan Tennessee

Tèks ofisyèl etid la (Anglè)

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Sarah Cannon Research Institue, Nashville
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Tennessee Oncology Chattanooga, Chattanooga
  • University of Tennessee Medical Center, Knoxville
  • Baptist Memorial Hospital-Memphis, Memphis
  • ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

  • University of Tennessee Medical Center, Knoxville
  • Baptist Cancer Center, Memphis
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Jun 26, 2026 · NCT04614103

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Baptist Memorial Hospital Baptist Cancer Center, Memphis
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.